A phase I clinical trial of Ipsc-derived Mscs (Cyp-001) in steroid-resistant acute Gvhd: two year follow-up results
Kelly, K. Bloor, Adrian Patel, A. Griffin, J. E. Radia, R. Yeung, D. T. Slukvin, I. Rasko, J.
Kelly, K.
Bloor, Adrian
Patel, A.
Griffin, J. E.
Radia, R.
Yeung, D. T.
Slukvin, I.
Rasko, J.
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Kelly K, Bloor A, Patel A, Griffin JE, Radia R, Yeung DT, et al. A Phase I Clinical Trial of Ipsc-Derived Mscs (Cyp-001) in Steroid-Resistant Acute Gvhd: Two Year Follow-up Results. Cytotherapy. 2023 Jun;25(6):S12-S. PubMed PMID: WOS:001041036100038.